Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Investors Business Daily
Investors Business Daily
Business
INVESTOR'S BUSINESS DAILY

McKesson Sees Its Composite Rating Rise To 96

McKesson saw its IBD SmartSelect Composite Rating rise to 96 Friday, up from 94 the day before.

The revised score means the stock currently tops 96% of all other stocks in terms of key performance metrics and technical strength. The market's biggest winners often have a 95 or higher grade in the early stages of a new price run, so that's a good starting point when looking for the best stocks to buy and watch.

McKesson is trading about 2% above a 632.59 entry from a cup with handle.

Looking For Winning Stocks? How To Invest In Both Bull And Bear Markets

The stock has an 86 EPS Rating, meaning its recent quarterly and annual earnings growth tops 86% of all stocks.

Its Accumulation/Distribution Rating of A shows heavy buying by institutional investors over the last 13 weeks.

The company reported a 4% increase in earnings for Q3. Revenue growth fell to 18%, down from 21% in the prior quarter.

McKesson holds the No. 2 rank among its peers in the Medical-Wholesale Drugs industry group. is the No. 1-ranked stock within the group.

This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.